![甲狀腺激素和抗甲狀腺藥Thyroid_第1頁](http://file4.renrendoc.com/view/327c7f1800828ff6a654ff1aa286bcde/327c7f1800828ff6a654ff1aa286bcde1.gif)
![甲狀腺激素和抗甲狀腺藥Thyroid_第2頁](http://file4.renrendoc.com/view/327c7f1800828ff6a654ff1aa286bcde/327c7f1800828ff6a654ff1aa286bcde2.gif)
![甲狀腺激素和抗甲狀腺藥Thyroid_第3頁](http://file4.renrendoc.com/view/327c7f1800828ff6a654ff1aa286bcde/327c7f1800828ff6a654ff1aa286bcde3.gif)
![甲狀腺激素和抗甲狀腺藥Thyroid_第4頁](http://file4.renrendoc.com/view/327c7f1800828ff6a654ff1aa286bcde/327c7f1800828ff6a654ff1aa286bcde4.gif)
![甲狀腺激素和抗甲狀腺藥Thyroid_第5頁](http://file4.renrendoc.com/view/327c7f1800828ff6a654ff1aa286bcde/327c7f1800828ff6a654ff1aa286bcde5.gif)
版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡介
甲狀腺激素和抗甲狀腺藥Thyroidhormonesandantithyroiddrugs北京協(xié)和醫(yī)學(xué)院基礎(chǔ)醫(yī)學(xué)院藥理學(xué)系葉菜英甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第1頁!SummaryThyroidhormones
Necessarytomaintainnormalmetabolism,growthanddevelopment.Hypothyroidism
CauseCretinismifithappensinembryoorneonatalperiod.Causemyxedemaifithappensinadultswhenthethyroidhormonecouldbeusedinreplacementtherapy.Hyperthyroidism
Asyndromcharacterizedbythyroidoversecretionandmetabolicdisordercausedbymultiplereasons.Itcanbetreatedwithradioactiveiodine(131I)irradation,antithyroiddrugsandoperation.甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第2頁!ThyroidhormonesThyroxine,T4Triiodothyreninumnatricum,T3Synthesizedandsecretedbythyroid甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第3頁!抗甲狀腺藥分為4類:硫脲類Thiourea碘和碘化物(復(fù)方碘溶液,lugol’ssolution)
)放射性碘(131I)β受體阻斷藥(心得安等從略)甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第4頁!ThyroidhormonesareiodicaminoacidsActiveponentsThyroxine,T4Triiodothyreninumnatricum,T3ChemicalconstitutionThyroidhormones甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第5頁!PhysiologicaldispositionofthyroidhormonesAbsorbedrapidlywhentakeorally,activityT3>T4,maintainingtimeT4>T3.T1/2ofT4andT3are6-7daysand1-2days,respectively.Deiodinationinmitochondriaofliverandkidney,eliminatedbykidneyafferconjugatedwithglucuronic
acidandsulfuricacid.T3,T4canalsopasstheplacentaandentermilk.Figure:theamountofnormaladults’thyroidhormonesproducedandmetabolizeddaily.甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第6頁!Stepsofthyroidhormonessynthesis,releaseandregulation(Ⅰ)Iodineuptake:I-inbloodcanbeuptakenintocellsbyiodinepumpintheadenocytemembrane.Theaminoacidscanbeusedtosynthesizethyroidglobulinincells.Iodineactivationandtyrosineiodation:I-uptakenintocellscanbeoxydizedtoactiveiodinebyperoxydase.ActiveiodinebindstotyrosineofTGandformsmonoiodotyrosine(MIT)and
diiodotyrosine(DTT).甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第7頁!Synthesis,storageandreleaseofthyroidhormone
GastrointestinalI-Blood
I-I-PeroxidaseIoTGTyrIodationMITDITCon-den-sationMIT+DITDIT+DITT3T4TGAcinarluminaStorageSynthesisReleaseActivationProteaseT3T4MIT一碘酪氨酸DIT二碘酪氨酸TG甲狀腺球蛋白blood甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第8頁!Mechanismofaction(figure)ItisbelievednowthatthethermogenicactionofT3andT4isduetotheincreaseofsodiumpumpsactivityonthecellmembrane.Na+,K+—ATPaseactivityATPutilizationADPconcentrationmitochondriarespirationoxideconsumptionandheatproductionThyroidhormones甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第9頁!ThyroidclinicalapplicationReplacementtherapymainlyTherapyanddiagnosisApplication
Cretinism
Treatingtheinfantsandchildrenassoonaspossiblecouldcurethemtonormal.Iftreatingtoolate,theyneedtobetreatedalifetime.
MucousedemaIncreasethedosageofthyroidpalletgradually.Toolargedosagemayaggravateheartdiseases.Patientsinashouldbegivenafistaid,whichisinfusionofT3(40-120μg)intravenoiusly,reinjection5-15μgevery6handoraladministrationwhenawake.Hypopituitarismpatientsshouldbegivencorticalhormonefirstandfollowedbythyroidhormone.Simplegoiter ReplacementtherapycaninhibitTSHoversecretionandcontracttheglandularorgan,3-6months.T3inhibitiontestDifferentialdiagnosisforPatientswithiodinehighuptake.甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第10頁!AntithyroidDrugsTherapiesofhyperthyrosisinclude131Iradiotherapy,exairesisormedication.Thioureahomologuesaremainlyusedclinically.Iodineandiodideareusedjustinpreparationforoperationsandthyroidcrisistherapy.βreceptorblockerscanbeusedasadjunctivetherapyforthyroidcrisis.甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第11頁!ThioureaPhysiologicalprocessAbsorption:
Easytobeabsorbedwhentakenorally.Thiouracilisthemostfasttobeabsorbed.Thebioavailabilityis80%andtheplasmaproteinbindingrateis75%.20-30minafteradministration,thedrugturnstobeeeffectivewithT1/2of2h.Imidazoleisabsorbedslowly.T1/2oftapazoleis6h.Distribution:
Organsgenerallyalloverthebodyandcanpasstheplacenta.Theconcentrationinlactoisabout3timesasinblood.Metabolism:
Mainlyinliver,fast.60%aredestroyedinvivo,therestareeliminatedbyurineinaconjugativeform.Carbimazolefunctionsafterturningintotapazoleinvivo.
甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第12頁!PathogenesisofExophthalmoshyperthyroidism
andfunctionlinkofthioureahomologuesThisdiseaseiscausedbyanautoimmuneIgGantibodyLATS(longactingthyroidstimulator),whichcanbindtothereceptorsonthyroidadenocytesandstimulateoversecretionofthyroidhormones.Thioureahomologuescannotonlyinhibitsynthesisofthyroidhormones,butalsoLATSinpatients,whichisakindofimmunoinhibition.甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第13頁!Comparisonamongmonthioureahomologuesdrugs
drugpotency
therapeuticdosemaintenanceadverseeffects
agranulemia (mg/d) doseincidence(%)incidence(%)
mildmoderatesevere
(mg/d)
Methyl 1 200-300 400-600 13.8 0.5 thiouracil 300-400 50-100Propyl 0.75 3.3 0.4thiouracilTapazole10 20-30 40-60 7.1 0.1Carbimazole10 30-40 5-10 1.9 0.8甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第14頁!IodineandiodideActionsandapplicationsLowdoseofiodine(physiologicaldose)couldpreventandcuresimple(endemicity)goiter.Add1/10000~1/100000potassiumiodideorsodiumiodidetosaltcouldpreventthedesease.LargedoseofiodinecouldinhibitthereleaseofT3andT4(duetotheinhibitionofTGhydratase).Usedasadjunctivetherapyforhyperthyroidism:①preparationbeforeoperation:administrationofaqueousiodinesolutiontwoweeksbeforeoperationdegeneratestheglandulartissue,decreasesvesselsandbleeding;②adjunctivetherapyforthyroidcrisis:couldbeusedbinedwiththioureahomologues.甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第15頁!Radioactiveiodine(131I)
T1/2is8.04daysActions
131Icouldbeuptakenbythroid,participateinthesynthesisofT3,T4andisstoredinfollecularcolloid.131Imainlygeneratesβray(99%)withaverageandmaximumpathof0.5mmand2mmrespectively.Sotheirradiationfunctionislimitedinthethyroid.Itcandestroytheglandularorganbutcanseldomdestroythesurroundingtissues.Γraygeneratedby131Iaccountsfor1%andcanbedetectedinvitro.Itisusuallyusedintheexaminationofthyroidiodineuptakingfunction.甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第16頁!Radioactiveiodine
AdverseeffectsandapplicationnotesHypothyroidismisthepredominantplication.Theadverseeffectscanbereducedbystrictdosecontrolandresistedbythyrine.PatientswithTotalwhitebloodcellslessthan3000/mm3arenotsuitabletotakeit.Soarepragnantandlactantwomen,patientsyoungerthan20yearsoldorwithsevereliverorkidneydeseases.甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第17頁!receptorblockersClinicalapplicationAdjunctivetherapyforhyperthyroidismandhyperthyroidismcrisis.MechanismofpharmacologicalactionsExcitedsympathetic-adrenergicsystemβ1receptorblockage—heartratedropCentralβreceptorblockage—toreduceanxietyβ2receptoronNAenerginicperipheralnerveendingspresynapticmembraneblockagereducesthereleaseofNA.AppropriatelyreduceT3,T4secretion.甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第18頁!硫脲類硫氧嘧啶類(thiouracil):甲基硫氧嘧啶(methykthiouracil)丙基硫氧嘧啶(propylthiouracil)咪唑類(imidazoles)他巴唑(Tapazole,甲巰咪唑methimazole)甲亢平(卡比馬唑Carbimazole)甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第19頁!甲狀腺激素的化學(xué)結(jié)構(gòu)甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第20頁!Synthesis,storageandregulationofthyroidhormonesIodineuptakeIodineactivationandtyrosineiodationCondensationandstorageDisintegrationandreleaseRegulation甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第21頁!Condensationandstorage:Inthethyroidglobulinmolecule,twoDTTsarecondensedtoT4,oneDTTandoneMITarecondensedtoT3,whichareallstoredinglandalveoluscolloid.Disintegrationandrelease:T3andT4arereleasedintobloodafterhydrolyzedbyproteases.Atthesametime,someofthemcanbeturnedbacktotyrosineandI-bydeiodinaseincellsandreused.Regulation:Bythepositiveandnegativefeedbackregulationofhypothalamus-anteriorlobe-thyroidaxis.HypothalamussecretsTRH,anteriorlobesecretsTSHandthyroidsynthesizeT3,T4.Stepsofthyroidhormonessynthesis,releaseandregulation(Ⅱ)甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第22頁!ThyroidhormonesMechanismofactionThebindingofT3andRincreasestheuptakeofaaandglucose,resultingintheentrancetocytoplasmofT3.AfterreactingwithCBP,T3iseduced.ThefreeT3canbindRinthemitochondriaandmakeADPtoATP.Besides,itcanenterthenuclearandbindRthere,whichcanincreasethetranscriptionofDNAandthecontentofmRNA.Thenthenewproteinscanbesynthesizedandplayroles.甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第23頁!Physiologicalandpharmacologicalactions
Keepnormalgrowthanddevelopment
PromotesynthesisofproteinsaswellasgrowthanddevelopmentofskeletonandCNS.T3,T4deficientsecretion:causescretinismininfantsandyoungchildrenandmucousedemainadults.
Promotemetabolismandincreaseheatproduction
Promoteoxidation,increaseoxygenconsumption,basalmetabolicrateandheatproduction.
Elevatesensitivityofsympathetic-adrenalsystem
Nervousness,trembling,heartbeatspeedup,bloodpressureincrease甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第24頁!AdverseeffectsAdverseeffectOverdoseCombinationContraindicationhyperthyreosisoldpeopleheartdiseasebishydroxycoumarindantinaoraspirindiabeteshypertensionCoronaryheartdiseasepyknocardiathyroidcrisis:anxiety,fear,restlessness,highbodytemperature,increaseandirregularheartrate,increasepulsepressure,congestiveheartfailurewithvomit,diarrheaanddehydrationwhichleadtoaanddeathAnginaorheartinfarctionIncreasetoxicityofthyroidhormone甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第25頁!硫脲類硫氧嘧啶類:甲基硫氧嘧啶丙基硫氧嘧啶咪唑類他巴唑(又稱甲巰咪唑)甲亢平(又稱卡比馬唑)甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第26頁!PharmacologicalactionsInhibitperoxydaseinadenocytes,whichresultsintheinhibitedoxydationofI-toI0.Then,theiodationandcoupleoftyrosinescanbestopped.SothebiosynthesisofT3andT4isinhibited.Buttheeffectoccursslowlyastheiodineuptakeandthehormonealreadysynthesizedarenoteffected.LongtimemedicationcanleadtodecreaseofT3andT4,whichfeedbackincreasesthesecretionofTSHandmakesthyroidhyperplasyandhyperemicpensatorily.PropylthiouracilcaninhibitT4turningtoT3andcontrolT3levelinblood.Soitisthefirstchoiceinhyperthyroidismcrisis,severehyperthyroidismandpregnanthyperthyroidism.Inhibitimmuno-system(ashyperthyroidismisrelatedwithabnormalimmunoreactions).Thiourea甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第27頁!ThioureaClinicalapplicationHyperthyroidism
Forwhohasmildsymptomsandisnotsuitabletohaveoperationsand131Iradiotherapy.GiveLargerdoseatthebeginning.After1~3months,symtomsdecreasedandbasalmetabolicratereturnstoalmostnormal.Reducetomaintainingdosewithaperoidof1~2years.Alsocanbeusedasadjunctivetherapyof131Iradiotherapy.
Preparationbeforeoperation
Medicationbeforeoperationisgoodtodecreasebleedinginoperationandpreventthyroidcrisisafteroperation.Adjunctivemedicationofthyroidcrisis
Besidesintegratemeasures,largedoseofThioureahomologuescanbeusedasadjunctivetherapy,SoisPropranolol.甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是第28頁!ThioureaAdverseeffects
Althoughtherearelotsofadverseeffectsofthioureahomologues,incidencesofpropylthiouracilandtapazolearelower,3%and7%respectively.Commonadverseeffects:
Skinrash,headache,dinus,gastrointestinalunfortable,fatigueandsoon.
Severeadverseeffects:
Bonemarrowdepression,agranulocytosisandsoon.Note:Periodicinspectionofhemogram.Themedicationshoulebestoppedifthesymptomsaspharyngalgia,fever,cathaeresisoccur.Thyroidcancerpatientsareforbiddentotake.甲狀腺激素和抗甲狀腺藥Thyroid共33頁,您現(xiàn)在瀏覽的是
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 2025年度建筑工地施工現(xiàn)場綠化養(yǎng)護(hù)合同標(biāo)準(zhǔn)
- 2025年度工業(yè)地皮買賣合同風(fēng)險(xiǎn)評(píng)估與控制服務(wù)協(xié)議
- 金華浙江金華市婺城區(qū)三江街道社區(qū)衛(wèi)生服務(wù)中心招聘工作人員筆試歷年參考題庫附帶答案詳解
- 金華浙江金華義烏市中心醫(yī)院基建總務(wù)科非編人員招聘筆試歷年參考題庫附帶答案詳解
- 重慶2025年重慶文理學(xué)院招聘39人筆試歷年參考題庫附帶答案詳解
- 漯河2024年河南共青團(tuán)漯河市委所屬事業(yè)單位引進(jìn)高層次人才筆試歷年參考題庫附帶答案詳解
- 淄博2024年山東淄博機(jī)電工程學(xué)校招聘教師筆試歷年參考題庫附帶答案詳解
- 汕尾2025年廣東汕尾陸河縣第一批城鎮(zhèn)公益性崗位招聘筆試歷年參考題庫附帶答案詳解
- 杭州浙江杭州市上城區(qū)行政審批服務(wù)管理辦公室編外人員招聘筆試歷年參考題庫附帶答案詳解
- 2025年中國企業(yè)管理軟件市場調(diào)查研究報(bào)告
- 布草類送洗記錄表
- 三年級(jí)數(shù)學(xué)口算題300道 (可直接打印)
- 益生芽孢桿菌體外抑菌活性及耐藥性研究
- 2023數(shù)聯(lián)網(wǎng)(DSSN)白皮書
- 消防設(shè)施操作和維護(hù)保養(yǎng)規(guī)程
- 反面典型案例剖析材料范文(通用6篇)
- 社區(qū)養(yǎng)老驛站運(yùn)營方案模版
- 鐵道概論(高職)PPT完整全套教學(xué)課件
- 餐飲行業(yè)品牌介紹商務(wù)宣傳PPT模板
- 關(guān)于中小企業(yè)人才流失的調(diào)查分析報(bào)告畢業(yè)論文
- 教科版五年級(jí)下冊科學(xué)同步練習(xí)全冊
評(píng)論
0/150
提交評(píng)論